Back to Results
First PageMeta Content
Pharmacology / Biotechnology / Eculizumab / Immunosuppressants / Pharmaceutical industry / Food and Drug Administration / Bacillus thuringiensis / Alexion Pharmaceuticals / Form FDA 483 / Medicine / Pharmaceutical sciences / Biology


FDA Indpection Observation dated 06 August 2012
Add to Reading List

Open Document

File Size: 4,73 MB

Share Result on Facebook
UPDATE